Can synthetic biology help Vanderbilt University Medical Center researchers develop therapeutic antibodies in only 90 days?

DNA synthesis

Home » Emerging technologies » DNA synthesis

DNA Script

DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 200-Nucleotide Strand of DNA

Dr. Geoff Smith and Dr. Robert Nicol join the newly created Advisory Board as the company gears up to commercialize its trailblazing enzymatic DNA synthesis technology. MARCO ISLAND, Fla.–(BUSINESS...

Why China is primed to be the ultimate synbio market

Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations

February 07, 2019 04:04 PM Eastern Standard Time SAN FRANCISCO –(BUSINESS WIRE)– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality...

Evonetix appoints Stephanie Brooking as Head of Product Management

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

News digest #255 – What is the future of DNA synthesis? + The next generation of natural sweeteners

DNA synthesis panel

The future of DNA synthesis

evonetix

Evonetix establishes scientific advisory board

plant

Four synthetic biology startups to watch in 2019

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

DNA Script

DNA Script Creates U.S. Subsidiary and Expands Executive Team in the U.S.

Emily Leproust

A big IPO for synthetic biology: Twist rings the Nasdaq bell today

News Digest #247 – Twist’s IPO, Ginkgo’s Bioworks4, iGEM’s winners, and Geltor’s Series A

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

Touchlight Genetics

Janssen Biotech and Touchlight announce collaboration